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Abstract
The outcome of viral infections is dependent on the function of CD8+ T cells which are tightly regulated by costimulatory
molecules. The NK cell receptor 2B4 (CD244) is a transmembrane protein belonging to the Ig superfamily which can also be
expressed by CD8+ T cells. The aim of this study was to analyze the role of 2B4 as an additional costimulatory receptor
regulating CD8+ T cell function and in particular to investigate its implication for exhaustion of hepatitis C virus (HCV)-
specific CD8+ T cells during persistent infection. We demonstrate that (i) 2B4 is expressed on virus-specific CD8+ T cells
during acute and chronic hepatitis C, (ii) that 2B4 cross-linking can lead to both inhibition and activation of HCV-specific
CD8+ T cell function, depending on expression levels of 2B4 and the intracellular adaptor molecule SAP and (iii) that 2B4
stimulation may counteract enhanced proliferation of HCV-specific CD8+ T cells induced by PD1 blockade. We suggest that
2B4 is another important molecule within the network of costimulatory/inhibitory receptors regulating CD8+ T cell function
in acute and chronic hepatitis C and that 2B4 expression levels could also be a marker of CD8+ T cell dysfunction.
Understanding in more detail how 2B4 exerts its differential effects could have implications for the development of novel
immunotherapies of HCV infection aiming to achieve immune control.
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Introduction
The outcome of viral infections is dependent on the function of
CD8+ T cells. The activity of CD8+ T cells is tightly regulated by
costimulatory molecules which are expressed on the cell surface.
Upon interaction with their respective counterparts, various
intracellular signalling pathways can be modified leading to
altered effector functions [1].
Infection with the hepatitis C virus (HCV) results in persistent
infection in the majority of cases [2]. The mechanisms leading to
chronicity are yet poorly understood. Besides viral escape
mutations HCV-specific CD8+ T cells are functionally impaired
and lack key effector functions such as cytokine production,
proliferation and cytotoxicity [3,4]. Virus-specific CD8+ T cell
responses generated during the early onset of HCV infection are
strong and multispecific, however, in settings of persistent virus
infections virus-specific T cells gradually become exhausted [5,6].
The mechanisms leading to exhaustion of T cells are only partially
understood, beside changes in the cytokine milieu and the lack of
CD4+ T cell help [7,8], altered expression levels of coinhibitory
molecules may also be of importance. In mouse models of
persistent viral infections exhaustion of virus-specific CD8+ T cells
was shown to be linked to the expression of the coinhibitory
molecule PD1 [9,10]. Subsequently, also in human chronic viral
infections impaired CD8+ T cell functions have been reported to
be associated with PD1 expression [5,11,12]. However, the
susceptibility to blockade of PD1 signaling varied between
individuals and PD1 blockade alone was not able to restore
function of intrahepatic HCV-specific CD8+ T cells [13].
Similarly, it was shown that HCV-specific CD8+ T cells in acute
hepatitis C can be functional despite continued PD1 expression
[14]. These findings implicate that multiple factors might be
involved in the control of CD8+ T cell function and establishment
of T cell exhaustion. Consequently, studies performed in mouse
models with persistent viral infections demonstrated that func-
tionally exhausted cells showed expression of multiple costimula-
tory molecules [15].
Besides PD1 one of the costimulatory molecules identified being
upregulated in exhausted virus-specific CD8+ T cells is the NK
cell receptor 2B4 (CD244). This molecule expressed on the cell
surface belongs to the family of SLAM-related receptors and
contains two cytoplasmatic ITSM (Immunoreceptor Tyrosine-
based Switch Motif) [16], which get phosphorylated upon ligation
with the high-affinity counterpart CD48 [17]. Initially, 2B4 was
described as a costimulatory receptor enhancing NK and CD8+ T
cell functions [18,19], but a recent study showed that 2B4 can
elicit both activating as well as inhibitory signals on NK cells [20].
Importantly, the consequence of 2B4 ligation is dependent on the
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of intracellular adaptor molecules. Interestingly, 2B4 signalling can
occur via different adaptor molecules, while the recruitment of
SAP (SLAM-associated protein) is supposed to cause an activation
of the cell, involvement of the adaptor molecule EAT-2 (EWS-
Fli1-activated transcript 2) seems to result in inhibitory signaling
[21]. 2B4 has recently been described to be expressed also on
HBV- and HCV-specific [22] CD8+ T cells, however, functional
consequences of 2B4 stimulation have not been investigated yet.
Due to the costimulatory potential and dual function of 2B4, we
aimed to investigate the role of 2B4 for the control of HCV-
specific CD8+ T cell function.
Results
2B4 expression on virus-specific CD8+ T cells
As 2B4 can be expressed not only by NK cells but also by CD8+
T cells we first aimed to investigate if 2B4 is also detectable on
virus-specific CD8+ T cells in latent infections (CMV, EBV) and
after resolved infections (Influenza A). As shown in Figure 1a, we
observed a distinct pattern of 2B4 expression on these virus-
specific CD8+ T cells in healthy individuals. While CMV- and
EBV-specific CD8+ T cells displayed a high frequency of 2B4
expression (CMV: mean 96% 65.6%; EBV: mean 79% 618.7%,
respectively), only a proportion of Flu-specific CD8+ T cells were
positive (mean 29% 621.9%; see Figure 1a). 2B4 expression levels
were also lower on Flu-specific than on CMV- or EBV-specific
CD8+ T cells (average 2B4 MFI 25 616.6 vs. 163 614.9 and 88
638.0, respectively; data not shown).
Expression of 2B4 on CD8+ T cells in viral hepatitis
We next asked for the expression of 2B4 on virus-specific CD8+
T cells in both patients with acute viral hepatitis and in patients
with chronic hepatitis C. HCV and HBV-specific CD8+ T cells
during acute symptomatic infection showed a high frequency of
2B4 expression (mean 85% 610.3% and 74% 610.7; average
MFI 97 638.9 and 83 636.9, respectively; see Figure 1b). On
HCV-specific CD8+ T cells from patients with persistent HCV
infection the frequency of 2B4 expression was slightly lower than
in acute patients, here about three quarter of virus-specific CD8+
T cells expressed 2B4 with a considerable inter-individual
variability (mean 70% 6 26%, average MFI 108 660.1). The
level of 2B4 expression on HCV-specific CD8+ T cells in patients
with chronic hepatitis C seemed to be lower in subjects showing
viral sequence variants in the respective epitopes. However, in
those individuals where the viral sequence was matching to the
peptide sequences used not only high 2B4 MFIs could be observed
on virus-specific CD8+ T cells, but also low expression levels of
2B4 could be found (see online Supplementary Table S1).
In order to assess the frequency of 2B4 expression on bulk
CD8+ T cells we screened PBMCs ex vivo for 2B4. We therefore
used PBMCs obtained from patients with chronic hepatitis C
infection, patients with acute symptomatic hepatitis C and
hepatitis B virus infection and analyzed 2B4 expression by flow
cytometry in comparison to samples from healthy individuals.
Generally, the frequency of 2B4 expression on bulk CD8+ T cells
showed a large inter-individual variability in all cohorts analyzed
(Figure 1c). In all patient cohorts a higher frequency of 2B4
expression on CD8+ T cells as compared to healthy controls could
be found (acHC: mean 58% 619.5%; acHB: mean 53% 618.4%;
chrHC: mean 45% 617.1% and healthy: mean 39% 616%;
respectively; see Figure 1c). No correlations of 2B4 expression
frequency on total CD8+ T cells with viral load, AST or ALT
levels or other clinical marker of liver disease could be seen (data
not shown). In addition, 2B4 expression was studied on liver-
infiltrating CD8+ T cells from healthy liver tissues which stained
highly 2B4-positive in 85% to 98% of cases (mean 79% 617.5%,
see Figure 1c) with higher relative levels of 2B4 expression (average
MFI 214666.7, data not shown) as compared to peripheral
lymphocytes (Figure 1c).
Upregulation of 2B4 expression levels in persistent
infections
To investigate upregulation of 2B4 expression on tetramer+ T
cells as compared to the respective bulk CD8+ T cells, we
calculated a ratio of 2B4 expression levels by dividing the 2B4 MFI
on tetramer+ by the 2B4 MFI on bulk CD8+ cells from the
respective individual. A ratio .1 indicates higher expression and a
ratio ,1 indicates lower 2B4 expression on tetramer+ CD8+ T
cells as compared to bulk CD8+ T cells of each respective
individual. Of note, in healthy individuals the level of 2B4
expression on CMV- and EBV-specific CD8+ T cells showed a
selective upregulation as compared bulk CD8+ T cells (mean ratio
MFI CMV+: 1.8361.1 and mean ratio MFI EBV+: 2.461.4,
respectively, see Figure 1d). This was not the case, however, for
Flu-specific CD8+ T cells which in the majority of cases showed
lower levels of 2B4 expression as compared to the respective bulk
CD8+ T cells (mean ratio MFI Flu+: 0.760.5). Importantly, the
level of 2B4 expression was selectively increased on HCV-specific
CD8+ T cells as compared to the respective bulk CD8+ T cells
(mean ratio MFI chrHC 2.162.4; see Figure 1d) in chronic
hepatitis C. In contrast, virus-specific CD8+ T cells from patients
with acute HCV or HBV infection showed almost equal 2B4
expression intensities as compared to the respective bulk CD8+ T
cells (mean ratio MFI acHC 1.160.3 and mean ratio MFI acHB
1.260.5, respectively). Interestingly, the rank order for 2B4
expression between different groups was different between MFI
ratios and frequency of 2B4+ cells. For further analysis, grouping
in 2B4 high versus 2B4 low expression was performed based on
the expression level of 2B4 on tetramer-positive cells (2B4 MFI).
We next investigated 2B4 expression on CMV-, EBV- and Flu-
specific CD8+ T cells in patients with chronic hepatitis C. A
higher frequency of 2B4 expression on Flu-specific cells was
Author Summary
Infection with the hepatitis C Virus (HCV) is a world-wide
health burden, the infection becomes persistent in the
majority of cases. In chronic patients HCV-specific immune
responses are weak, HCV-specific CD8+ T cells were shown
to be functionally exhausted and to be negatively
controlled by costimulatory molecules like PD-1. Here,
we show that the costimulatory molecule 2B4 (CD244) is
also involved in the regulation of HCV-specific CD8+ T cell
responses and that 2B4 expression is selectively upregu-
lated on virus-specific CD8+ T cells in persistent infections.
Proliferation of HCV-specific CD8+ T cells from chronic
patients increased by 2B4 cross-linking only if the ex vivo
2B4 expression was low, while we could observe no effect
on samples with high 2B4 expression levels. Of note,
expression of the intracellular 2B4 adaptor molecule SAP,
which leads to an activation of the cell, decreased with
higher 2B4 expression levels. Finally, we were able to show
that 2B4 cross-linking can counter-act enhanced prolifer-
ation of HCV-specific CD8+ T cells seen upon PD-1
blockade. Thus, our study provides new insights into the
regulation of CD8+ T cell responses demonstrating an
implication of the costimulatory molecule 2B4.
2B4 on HCV-Specific CD8+ T Cells
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while no difference was seen for CMV- or EBV-specific CD8+ T
cells. The level of 2B4 expression (2B4 MFI), however, was lower
on Flu-specific T cells as compared to CMV- and EBV-specific
cells (Figure 2e, right panel), thus showing the same pattern as seen
in healthy individuals.
Phenotype of 2B4+ CD8+ T cells
To evaluate whether 2B4 expression is linked to a certain
phenotype we analyzed the memory status of 2B4+ CD8+ T cells
(Figure 2a) by costaining for common differentiation and
costimulatory markers. As demonstrated in Figure 2b, 2B4+
CD8+ T cells show a trend towards an elevated coexpression of
CD45RA (mean 57% 623%) and reduced coexpression of CCR7
(mean 25.5% 626%). Thus, 2B4+ CD8+ T cells preferentially
show an effector or effector memory phenotype. Similar patterns
were seen using CD127 and CD62L (CD62L+ CD127-: mean
25.7% 620.8%; CD62L+ CD127+: mean 13.4% 611.4%;
CD62L- CD127+: mean 18.5% 613.9%; CD62L- CD127-:
mean 42.3% 622.3%). However, as expression levels of these
markers show a high inter-individual variability there was no clear
link to any memory population subtype.
Costaining of 2B4+ CD8+ T cells with PD1 and CD57 showed
a clear correlation of expression of these costimulatory molecules
with all PD1+ CD8+ T cells being also positive for 2B4 (Figure 2c).
Of note, this was not the case vice versa as not all 2B4+ CD8+ T
Figure 1. 2B4 expression on virus-specific and bulk CD8+ T cells. (A) CMV-pp65-, EBV-BMLF1- and Influenza A virus-specific cells from healthy
individuals were stained for 2B4 expression. Representative FACS plots are shown on the left, summarized data of frequency of 2B4 expression on
virus-specific CD8+ T cells from all individuals analyzed are shown in the plot on the right side. (B) Virus-specific CD8+ T cells from patients with
chronic hepatitis C (upper left panel; n=24), acute hepatitis C (middle left panel; n=7) and acute hepatitis B (lower left panel; n=5) were stained ex
vivo for 2B4. High 2B4 expression frequency could be found in all three cohorts. Representative FACS plots of three individuals each are shown on the
left side, summarized data of frequency of 2B4 expression on virus-specific CD8+ T cells from all individuals analyzed are shown in the right plot. (C)
Expression of 2B4 on bulk CD8+ T cells was analyzed ex vivo by flow cytometry, values given represent frequency of expression of 2B4 on total CD8+ T
cells in percent. PBMC from healthy individuals (closed circles, mean 39% 616%; n=48), patients with chronic hepatitis C (open circles, mean 45%
617%; n=78) or acute hepatitis C (open squares, mean 58% 619.5%; n=13) or acute hepatitis B (open triangles, mean 53% 618.4%; n=6) and T
cells from healthy liver tissues (open diamonds, mean 87% 613%; n=7) were isolated and directly stained for 2B4. Cells were gated on CD14-, CD19-
and CD56-negative lymphocytes and CD8+ T cells. 2B4 expression frequency on bulk CD8+ T cells from patients with chronic hepatitis C and acute
hepatitis C was found to be significantly increased as compared to healthy controls (p=0.04 and p=0.004, respectively). (D) Ratio of 2B4 expression
levels. Mean 2B4 expression levels on virus-specific T cells was divided by the mean 2B4 expression level on the respective individual’s bulk CD8+ T
cells in order to calculate the ratio for showing selective change of 2B4 expression. A ratio .1 indicates higher expression on tetramer+ CD8+ T cells
and a ratio ,1 indicates lower 2B4 expression levels on tetramer+ CD8+ T cells as compared to bulk CD8+ T cells. Ratios were calculated for cells
specific for CMV-pp65 (closed squares; mean1.8261.1; n=8), EBV-BMLF-1 (closed triangles up; mean 2.461.4; n=19) and Flu-M1 (closed triangles
down; mean 0.760.5; n=24) in healthy individuals, for HCV-specific CD8+ in patients with chronic hepatitis C (open squares; mean 2.162.4; n=26)
and acute hepatitis C (open diamonds; mean 1.160.3; n=10) and for HBV-specific CD8+ T cells in patients with acute hepatitis B (open triangles up;
mean 1.260.5; n=5). Cells were gated on CD14-, CD19- and CD56-negative lymphocytes and CD8+ T cells. (E) Expression of 2B4 on CMV-, EBV- and
Flu-specific CD8+ T cells in healthy individuals as compared to chronic HCV patients. Analyzing the frequency of 2B4 expression in the two cohorts
revealed an elevated frequency of 2B4 expression on Flu-specific T cells in chronic HCV patients as compared to healthy individuals (left plot).
However, 2B4 expression levels on Flu-specific CD8+ T cells were lower than on CMV- and EBV-specific T cells as seen before in healthy individuals.
doi:10.1371/journal.ppat.1002045.g001
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coexpression could be observed with other costimulatory mole-
cules such as CD16 or CD161, where expression of these markers
was also always associated with 2B4 expression.
Consequences of 2B4 cross-linking for CD8+ T cell
effector functions
To investigate whether 2B4 has potential costimulatory effects
on bulk and virus-specific CD8+ T cells different effector functions
of CD8+ T cells were analyzed after 2B4 stimulation. Therefore,
the anti-2B4 antibody clone C1.7 was used which is known to
activate 2B4 by cross-linking [18]. Of note, anti-2B4 alone without
further stimulation did not cause any alteration of T cell
proliferation (data not shown) supporting the concept that 2B4
acts as a costimulatory molecule modifying T cell responses to
antigenic stimulation. We generated in vitro cultures using PBMCs
and stimulated with anti-CD3/CD28 or virus-derived peptides
and with or without addition of anti-2B4 antibody in the cell
culture.
In line with the report by Chlewicki et al. [20], where the
outcome of 2B4 ligation was described to be dependent on the
surface expression intensity of 2B4, we observed a difference in the
Figure 2. Characteristics of 2B4+ CD8+ T cells. (A) For analysis of the phenotype of 2B4+ CD8+ T cells were gated as demonstrated on live cells
and after exclusion of CD14/CD19/CD56+ cells (upper panel). Exemplary staining of 2B4 expression on CD8+ T cells in healthy individuals is shown in
the lower panel. (B) The maturation status of 2B4+CD8+ T cells was analyzed by costaining with CCR7, CD45RA, CD62L and CD127. The frequencies of
expression of these markers are shown in the left Figure. Expression showed a high inter-individual variability (CCR7+ CD45RA-: mean 40.5%
620.9%;CCR7+ CD45RA+: mean 12.6%614.8%; CCR7- CD45RA+: mean 7.7% 610.6%; CCR7- Cd45RA-: mean 39.2625.7; CD62L+ CD127-: mean 25.7%
620.8%; CD62L+ CD127+: mean 13.4% 611.4%; CD62L- CD127+: mean 18.5% 613.9%; CD62L- CD127-: mean 42.3% 622.3%) and expression of 2B4
on CD8+ T cells could not be linked to a specific memory population subtype. Representative FACS plots are shown on the right side. Cells were
gated on CD14/CD19/CD56-negative cells and 2B4+CD8+ T cells. (C) Coexpression of 2B4 with the coinhibitory molecule PD1, CD57, CD16 and
CD161. Cells were stained for 2B4 together with PD1, CD57, CD16 or CD161, plots are gated on CD14/CD19/CD56-negative lymphocytes. All CD8+ T
positive for either PD1, CD57, CD16 or CD161 were found to simultaneously be also positive for 2B4 as shown in the representative FACS plots.
doi:10.1371/journal.ppat.1002045.g002
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ex vivo. While 2B4 cross-linking enhanced proliferation of CD3/
CD28-stimulated 2B4-low cells in a 7 day CFSE assay, no such
effect could be observed for cells with high 2B4 expression
(Figure 3a). Similarly, other effector functions like degranulation as
a marker for cytotoxicity and IFNc production of bulk CD8+ T
cells increased after anti-CD3/CD28 stimulation and additional
2B4 cross-linking only in 2B4-low expressing cells (Figure 3b).
Again, this was not the case for samples with high 2B4 expression.
However, not all samples with low 2B4 expression levels increased
in their effector functions after 2B4 cross-linking.
The functional importance of 2B4 expression for CD8+ T cells
further became evident when stimulating sorted 2B4+ and 2B4-
CD8+ T cells. In this case, only the 2B4+ T cells responded to
TCR-stimulation with an increased degranulation (see online
supplementary Figure S1).
The findings on altered effector functions of anti-CD3/28-
stimulated bulk CD8+ T cells were confirmed for antigen-specific
CD8+ T cells. High 2B4-expressing CMV- and EBV-specific
CD8+ T cells showed no increase and in some cases even a
decrease of expansion of tetramer positive cells after peptide-
specific stimulation and additional 2B4 cross-linking (CMV mean
SI=0.93 +/2 0.2 and EBV mean SI=0.8 +/2 0.3, respectively;
see Figure 3c, left side). In contrast, 2B4-low Flu-specific CD8+ T
cells showed an elevated peptide-induced proliferation upon
simultaneous 2B4 cross-linking as compared to peptide stimulation
alone (mean SI= 1.66 +/2 1.48, Figure 3c, right side). These
observations could be confirmed by using the CFSE assay as
readout showing an increased proliferation of Flu-specific but not
CMV- or EBV-specific CD8+ T cells. These experiments
confirmed an increased proliferation of antigen-specific T cells
and not only a relative enrichment in cultures (Figure 3d).
Similarly, degranulation and IFNc production of Flu-specific T
cells could be enhanced through 2B4 cross-linking, while CMV- or
EBV-specific T cells did not respond or showed decreased of
effector functions upon 2B4 stimulation (Figure 3e).
Of note, cross-linking of 2B4 using a monoclonal antibody had
no impact on the survival and viability of cells. No increase in
Annexin-V positive cells was observed when treating cells with
anti-2B4 and with or without additional anti-CD3/28 stimulation
of the cells (see online supplementary Figure S2). Also, after in vitro
culture no differences in cell viability between the different cell
culture conditions could be seen as analyzed by flow cytometry
(according to ‘‘live gate’’, data not shown).
Importance of 2B4 for HCV-specific CD8+ T cell
expansion
Persistent HCV infection is characterized by the functional
exhaustion of the HCV-specific CD8+ T cells. In settings of
persistent infection PD1 was shown to be upregulated contributing
to the dysfunctionality of these cells. As we could show that 2B4
expression is selectively upregulated on HCV-specific CD8+ T
cells, we next wanted to investigate the impact of 2B4 on the
function of HCV-specific CD8+ T cells in persistent HCV
infection.
We therefore studied peptide-specific proliferation of HCV-
specific CD8+ T cells in a 10 days in vitro culture experiment and
determined the expansion of tetramer-positive cells. Overall, 86
patients with chronic hepatitis C were screened for HLA-A2 and
39 cell lines were established. 24 cell lines showed detectable
tetramer-positive cells and enriched HCV-specific CD8+ T cells
could be detected in 19 (79%) cell lines in at least one of the
culture conditions. 10 cell lines responded to peptide stimulation
alone (see Table 1). Overall, the effects of cross-linking 2B4 varied
between individuals. Additional stimulation of 2B4 resulted in an
enrichment of HCV-specific CD8+ T cells in 5 individuals (26%)
(stimulation index referring to peptide stimulation alone).
Interestingly, all of these five samples responding to 2B4
stimulation displayed low 2B4 expression levels on the respective
virus-specific cells ex vivo (see table 1, p=0.052 comparing 2B4-low
versus 2B4-high tetramer-positive samples). Examples of different
cell lines are shown in Figure 4. In addition there was a trend of
reduced responsiveness to peptide stimulation alone for 2B4-high
samples (2/10 versus 8/15 responding cell lines, p=0.13). A
detailed listing of all cell lines analyzed including the respective ex
vivo frequencies of HCV-specific T cells is given in table 1.
We also analyzed the effect of blocking 2B4 instead of cross-
linking on the expansion of HCV-specific CD8+ T cells from
chronic hepatitis C patients using a different anti-2B4 antibody. In
this setting, we were also able to achieve an increased proliferation
of HCV-specific T cells after 10 days of culture in some
individuals. Of note, in those cases where the expansion of
HCV-specific T cells increased upon 2B4 blockade, no effect or
even a negative effect was induced through 2B4 cross-linking (see
online supplementary Figure S3). Similarly, when 2B4 cross-
linking resulted in an enhanced proliferation of HCV-specific cells,
no effect could be seen with blocking 2B4.
Expression of the 2B4 adaptor protein SAP
We next asked whether the variability in the effect of 2B4
stimulation might also be influenced by the signalling pathways
elicited. 2B4 ligation can lead to the recruitment of different
intracellular adaptor proteins to the cytoplasmic domain of 2B4.
As the binding of the adaptor molecule SAP leads to a positive
signalling and activation of the cell and as the outcome of 2B4
ligation seems to be dependent on the availability of intracellular
SAP molecules as described by Chlewicki et al. [20], we analyzed
the expression of SAP in CD8+ T cells in order to elucidate
whether the role of 2B4 during CD8+ T cell function and
functional exhaustion might be based on differences in SAP
expression. For this we used PBMCs from healthy individuals and
patients with chronic hepatitis C as well as isolated intrahepatic
lymphocytes and stained for intracellular SAP (Figure 5a). No
striking differences between SAP expression in peripheral CD8+ T
cells from healthy individuals and patients with chronic hepatitis C
could be observed. However, SAP contents in T cells isolated form
liver tissue tended to be lower as compared to peripheral
lymphocytes (Figure 5b). Moreover and importantly, SAP
expression differed between 2B4
hi and 2B4
lo CD8+ T cells as
SAP levels were significantly lower in 2B4
hi cells in both healthy
individuals (MFI 13616821 vs. 15666994; p=0.02), chronic
hepatitis C patients (MFI 10236734 vs. 11706698; p=0.005) and
intrahepatic T cells (MFI 8076255 vs. 10456222; p=0.03; see
Figure 5b and 5c). Thus, these findings might explain why HCV-
specific CD8+ T cells with high 2B4 expression levels showed a
reduction of proliferation upon 2B4 cross-linking, as the reduced
intracellular SAP availability results in inhibitory signalling.
Opposing effects of PD1 blockade and 2B4 cross-linking
on the proliferation of HCV-specific CD8+ T cells
It has been shown before that blockade of PD1 in vitro can
enhance HCV-specific CD8+ T cell proliferation and thereby
restore functionality of exhausted cells during persistent HCV
infection [23,24]. Similarly, we also observed an increase of HCV-
tetramer positive CD8+ T cells by addition of anti-PDL-1 in our
cell culture system with 6 out of 19 cell lines (31%) showing a
significant increase of tetramer-positive cells as compared to
peptide stimulation alone (see table 1). However, as also seen in
2B4 on HCV-Specific CD8+ T Cells
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inter-individual variability as no positive effect was observed in
several individuals analyzed (Figure 6a and 6b). This finding again
underlines that PD1 is not alone responsible for the functional
exhaustion of virus-specific CD8+ T cells during persistent
infections.
Recently, it was shown that multiple costimulatory receptors are
involved in the regulation of virus-specific CD8+ T cell function
during persistent infection in mice [25]. We therefore investigated
the effects of simultaneous PD1 blockade and 2B4 cross-linking on
the proliferation of HCV-specific CD8+ T cells. Interestingly, we
were able to observe an opposing responsiveness to PD1 blockade
and 2B4 stimulation. Those samples positively responding to 2B4
cross-linking did not show an increased proliferation induced by
PD1 blockade. Similarly, 2B4 cross-linking alone was ineffective in
those cases where proliferation increased upon PD1 blockade (data
not shown). Additionally and importantly, 2B4 stimulation was
able to counteract enhanced proliferation of HCV-specific CD8+
T cells induced by PD1 blockade. The observed increase of HCV-
specific proliferation was abrogated if 2B4 was cross-linked
Figure3. Alteration of CD8+ T cell effector function upon 2B4 cross-linking. (A) Bulk CD8+ T cells from healthy individuals showedan increase
in proliferation upon anti-CD3/28 stimulation and additional 2B4 cross-linking as compared to anti-CD3/28 stimulation alone. This, however, was only
the case for cells with a low 2B4 expression level ex vivo (left plots), while cells with high 2B4 expression level ex vivo could not be further enhanced by
2B4 cross-linking (right plots). Ex vivo 2B4 expression levels are indicated above the respective plot. Frequencies of CFSE-low CD8+ T cells are given,
representative plots are shown. (B) Additionally, the anti-CD3/28-induced degranulation (as analyzed by CD107a/b expression, left plot) and the IFNc
production (right plot) of bulk CD8+ T cells from healthy individuals with low ex vivo 2B4 expression levels could be enhanced by 2B4 cross-linking in
several individuals. Stimulation indices (SI) are shown referring to anti-CD3/28 stimulation alone. (C) Expansion of antigen-specific CD8+ T cells upon
peptide-specific stimulationcouldnot beenhancedbyadditional2B4-cross-linkinginthecaseof(2B4highexpressing)CMV-orEBV-specific CD8+Tcells
(left plot). However, expansion of (low 2B4 expressing) Flu-specific T cells increased upon additional 2B4 cross-linking in most individuals analyzed (right
plot).Stimulation indicesareshownreferringtopeptidestimulationalone.(D)ExpansionofFlu-specificCD8+Tcellsinducedbypeptidestimulation and
additional 2B4 cross-linking is due to an increased proliferation of antigen-specific T cells as seen by a higher frequency of CFSE-low cells. In contrast,
CMV- or EBV-specific T cells did not respond to additional 2B4 cross-linking. (E) Degranulation (squares) and IFNc production (triangles) of CMV- or EBV-
specific T cells from healthy individuals did not increase upon 2B4 cross-linking in addition to peptide stimulation (upper panels). In contrast, these
effector functions increased upon peptide stimulation and simultaneous 2B4 cross-linking in the case of Flu-specific T cells (lower panels).
doi:10.1371/journal.ppat.1002045.g003
Table 1. Expansion of HCV-specific CD8+ T cells in chronic hepatitis C patients.
chrHCV patient
# epitope ex vivo frequency medium +peptide +2B4-CL +PDL-1
+2B4-CL +
PDL-1
MFI 2B4 on
Tet+
#01 NS3-1073 0.08 0.02 0.02 0.01 0.01 0.00 lo
#01 NS3-1406 0.06 0.03 0.01 0.01 0.01 0.02 lo
#02 NS3-1073 0.026 0.09 0.31 4.92 0.10 0.10 lo
#03 NS3-1073 0.032 1.64 1.73 1.67 1.75 23.30 hi
#04 NS3-1073 0.02 0.21 0.33 0.20 0.13 0.17 hi
#05 NS3-1406 0.09 0.01 5.09 3.93 19.90 1.79 lo
#06 NS3-1073 0.22 0.16 0.76 1.67 4.71 1.99 lo
#07 NS3-1073 0.02 0.08 0.02 0.06 0.08 0.07 hi
#08 NS3-1073 0.1 0.09 2.01 0.81 4.40 1.92 lo
#08 NS5B 0.13 0.16 0.28 0.23 0.34 0.34 lo
#09 NS3-1073 0.02 0.85 20.30 6.03 15.70 1.36 lo
#10 NS5B 0.01 0.03 0.05 0.07 0.03 1.10 lo
#11 NS3-1406 0.03 0.08 4.38 3.68 5.04 2.64 lo
#11 NS3-1073 0.09 0.42 0.37 0.53 0.87 0.27 hi
#12 core132 0.01 0.06 0.04 0.11 0.08 0.06 lo
#12 NS3-1073 0.03 1.23 22.70 9.59 15.80 7.35 hi
#13 NS3-1073 0.009 0.02 0.06 0.08 0.04 0.03 hi
#14 NS3-1073 0.04 0.06 0.04 0.00 0.34 0.04 lo
#15 NS3-1406 0.04 0.29 0.36 2.14 0.35 0.33 lo
#15 NS3-1073 0.03 0.38 0.32 0.62 0.36 0.37 hi
#16 NS3-1073 0.028 0.37 2.10 0.51 0.97 1.29 hi
#17 core132 0.015 0.69 4.10 0.54 0.77 0.60 lo
#18 NS3-1073 0.12 2.72 3.93 7.74 4.29 2.71 lo
#19 NS3-1073 0.02 0.59 0.85 0.81 0.76 0.54 hi
Ex vivo frequencies and percentages of HCV-specific CD8+ T cells are displayed for all 24 cell lines, for which tetramer-positive cells were detectable after the 10 days
culture. 2B4 expression level according to the ex vivo MFI are indicated as ‘lo’ or ‘hi’. Responses to peptide stimulation alone are marked in grey. All culture conditions
with an at least 2fold increase of tetramer-positive cells as compared to peptide stimulation alone are indicated by black boxes. The highest frequency of tetramer-
positive CD8+ T cells detected in each cell line is indicated in bold numbers.
doi:10.1371/journal.ppat.1002045.t001
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19) the double combination of 2B4 cross-linking and PD1
blockade resulted in enhanced proliferation of HCV-specific
CD8+ T cells. In these cases however, neither 2B4 cross-linking
nor PD1 blockade alone showed any effect.
Discussion
In this paper we demonstrate that (i) 2B4 is expressed on virus-
specific CD8+ T cells during acute and chronic hepatitis C, (ii) that
2B4 cross-linking can lead to both inhibition and activation of
HCV-specific CD8+ T cell function, depending on expression
levels of 2B4 and the intracellular adaptor molecule SAP and (iii)
that 2B4 stimulation may counteract enhanced proliferation of
HCV-specific CD8+ T cells induced by PD1 blockade.
2B4 has first been described on human NK cells [26] and
previous studies showed that 2B4 can also be expressed on human
CD8+ T cells [27]. Recently, 2B4 expression has been
demonstrated also in patients with chronic hepatitis C [22]. We
here describe a rather high inter-individual variability of 2B4
expression on CD8+ T cells ranging from less than 10% of cells
expressing 2B4 to more than four fifths being 2B4 positive. The
majority of 2B4+ CD8+ T cells were differentiated effector
memory cells being CD45RA positive and CCR7 negative,
although 2B4 expression was not exclusively linked to a specific
memory subtype. Nevertheless, further phenotyping showed that
the expression of several other costimulatory molecules including
PD1 was almost always accompanied by simultaneous 2B4
expression.
During persistent virus infections CD8+ T cells can be
functionally impaired and may express high levels of PD1 which
control CD8+ T cell functions [9,23,28]. Recent data generated in
mouse models of chronic viral infections suggested that not only
single but multiple coinhibitory molecules are involved in the
control of exhausted virus-specific CD8+ T cells [25]. Gene array
Figure 4. Effect of peptide stimulation and simultaneous 2B4 cross-linking on the expansion of HCV-specific CD8+ T cells in patients
with chronic hepatitis C. Exemplary FACS plots from six different day10 cell lines analyzed are shown, frequency of HCV-tetramer+ cells of total CD8+
T cells areindicated. Samples were divided accordingtothedirect ex vivo expression intensity (MFI) of2B4onHCV-specific CD8+ T cellsinto 2B4MFI low
(left panel)and2B4MFIhigh (rightpanel). Cross-linking of 2B4resulted in anincreasedfrequency of HCV-specific CD8+ T cells in those samples with low
2B4 expression ex vivo, while for those samples with high expression no increase or even a decrease of proliferation was observed.
doi:10.1371/journal.ppat.1002045.g004
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PLoS Pathogens | www.plospathogens.org 8 May 2011 | Volume 7 | Issue 5 | e1002045Figure 5. Expression of SAP by CD8+ T cells. Intracellular staining for the 2B4 adaptor molecule SLAM-associated protein (SAP) was performed.
(A) Representative overlays of histograms for SAP staining (solid line) and respective 2ndry antibody only (tinted graphs) of peripheral CD8+ T cells
from healthy individuals (upper left), chronic hepatitis C patients (upper right) and isolated intrahepatic CD8+ T cells (lower left) are shown. MFI
values for both histograms are indicated. (B) Intracellular SAP content of CD8+ T cells differs with expression intensity of 2B4. Peripheral blood CD8+ T
cells from healthy individuals (left plot) and chronic hepatitis C patients (middle plot) and intrahepatic CD8+ T cells (right plot) were stained for 2B4
and intracellular SAP. Cells were gated according to 2B4 expression levels into 2B4lo and 2B4hi cells as shown and content of intracellular SAP was
determined by calculating the SAP MFI as indicated. SAP content was found to be lower in cells with high as compared to cells with low 2B4
expression levels. (C) Intracellular SAP staining of 2B4+ CD8+ T cells showed a significantly lower SAP expression intensity high 2B4 expression (2B4
hi)
as compared to cells with low 2B4 expression (2B4
lo) in healthy volunteers (left plot; p=0.02), patients with chronic hepatitis C (middle plot; p=0.005)
and intrahepatic cells (right plot; p=0.03).
doi:10.1371/journal.ppat.1002045.g005
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upregulated in exhausted virus-specific CD8+ T cells [15]. In line
with these findings, we also could demonstrate that HCV-specific
CD8+ T cells show an elevated expression of 2B4 in chronic
hepatitis C as compared to the respective individual’s bulk CD8+
T cells. Further, we could show that expression levels of 2B4 are
higher on HCV-specific CD8+ T cells as compared to the
respective individual’s bulk CD8+ T cells in chronic hepatitis C
patients suggesting that 2B4 might be involved in regulating T cell
effector functions in chronic infections. In addition, the increased
frequency of 2B4+ Flu-specific CD8+ T cells in chronic hepatitis C
suggest that cytokines in the context of chronic hepatitis C may
result in an unspecific upregulation of 2B4 on Flu-specific CD8+ T
cells. Another explanation could be a cross-reactive stimulation of
Flu-specific T cells in HCV infected individuals [29]. Moreover,
viral escape leading to sub-optimal T cell receptor stimulation may
in contrast be associated with a lower 2B4 expression as 2B4 levels
were usually low in those subjects showing viral sequence
variations in the respective epitopes. Similar findings have
previously been shown for other costimulatory molecules [22,30].
Cross-linking 2B4 using the C1.7 antibody has been shown to
stimulate cytotoxicity and cytokine production by NK cells [31].
In contrast, CD8+ T cell function was not altered if 2B4 alone was
engaged without simultaneous TCR stimulation [32,33] which is
in line with our own findings (data not shown). Still, a previous
report suggested that 2B4 costimulation may enhance in vitro
expansion of tumour-specific CD8+ T cells [33]. We here show
that 2B4 cross-linking may indeed alter effector functions of bulk
and antigen-specific CD8+ T cells like proliferation, degranulation
and IFNc production. Further and importantly, 2B4 stimulation
was able to enhance peptide-induced proliferation of HCV-
specific CD8+ T cells from patients with chronic hepatitis C.
Figure 6. Effect of PD1 blockade and simultaneous cross-linking of 2B4 on the proliferation of HCV-specific CD8+ T cells in patients
with chronic hepatitis C. PBMC were stimulated in vitro for 10 days with peptide alone or together with the indicated antibodies or antibody
combinations. (A) Tetramer staining of three representative cell lines are shown, numbers indicated represent percentages of HCV-tetramer+ cells of
CD8+ T cells. (B) Overview of all cell lines analyzed (n=20), stimulation indices (SI) of percentages of HCV-tetramer+ CD8+ T cells referring to medium
controls are given for samples stimulated with peptide alone, additional PD1 blockade or simultaneous PD1 blockade and 2B4 cross-linking. In most
cases cross-linking 2B4 in combination with PD1 blockade counter-acted the enhanced proliferation of HCV-specific CD8+ T cells seen upon PD1
blockade alone (6 out of 20). In some cases (3 out of 20) the double combination resulted in enhanced proliferation of HCV-specific CD8+ T cells, in
those cases however, blocking PD1 or stimulating 2B4 alone was ineffective.
doi:10.1371/journal.ppat.1002045.g006
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the findings of the stimulatory capacity of 2B4 cross-linking (data
not shown). However, this activating effect was only observed in
some but not all patients. We noted that responsiveness to 2B4
stimulation was linked with the ex vivo 2B4 expression levels, which
held true for HCV-specific CD8+ T cells as well as for CMV-,
EBV- and Influenza-specific CD8+ T cells. Virus-specific CD8+ T
cells with high 2B4 expression levels appeared to be insensitive
towards 2B4 stimulation or even showed a decrease in prolifer-
ation upon 2B4 cross-linking, while cells with lower 2B4 expression
still responded to 2B4 cross-linking. Future studies also need to
address in more detail the effects of 2B4 blockade versus 2B4 cross-
linking. 2B4 blockade may enhance effector functions of HBV-
specific CD8+ T cells in some patients with acute hepatitis B [34].
We identified a positive effect of 2B4 blockade preferentially in
those samples with higher 2B4 expression, while 2B4 cross-linking
was effective in 2B4-low expressing cells only.
The cause for these opposing functions of 2B4 could be explained
with the diverse signal transduction pathways elicited upon 2B4 cross-
linking which may lead to a dual function of 2B4. Different adaptor
molecules including SAP can be recruited to the intracellular tail of
2B4 [33,35]. Further studies showed that the expression density of
2B4 influences the outcome of 2B4 signalling. While cell activation
seemed to correlate to low 2B4 levels, high 2B4 expression and
insufficient availability of SAP molecules lead to an inhibition of cells
[20]. These data would explain our findings where 2B4 responsive-
ness was depended on the level of 2B4 expression. Indeed, we could
show that SAP expression was lower in 2B4-high versus 2B4-low
expressing CD8+ T cells. The low SAP content in 2B4-high cells may
induce inhibitory downstream signalling. In this setting, further
stimulation would not result in functional enhancement or might
even induce reduction of effector functions. This would also explain
the important finding that 2B4 cross-linking counteracted stimulatory
effects induced by PD1 blockade. Of note, stimulatory effects by 2B4
cross-linking versus PD1 blockade seemed to be rather exclusive as
either one of the mechanisms was only active alone and synergistic
effectswere rarelyobserved.SinceblockingPD1iscurrentlyexplored
already in clinical trials our findings may partially question this
therapeutic concept as PD1 positive cells are always 2B4 positive and
as 2B4 ligands are ubiquitously expressed.
Another 2B4 adaptor molecule is EAT-2, which is supposed to
confer inhibitory downstream signalling [36]. Future studies
should therefore also consider EAT-2 expression in relation to
SAP expression. However, one has to consider that not only the
presence of the signal transduction molecules, but also the
phosphorylation status of the intracellular domain of 2B4 is of
importance [37], potentially explaining the high inter-individual
variability observed in our study.
Obviously future studies should address several additional
issues. We here provide only first data supporting the hypothesis
that 2B4 plays a role in the regulation of CD8+ T cell functions.
However, the sample sizes are too low to draw definite conclusions
and thus confirmatory studies are needed. Only two co-activating
or co-inhibitory receptors potentially regulating CD8+ T cells
were investigated and thus additional costimulatory molecules
such as CTLA-4, TIM-3 or BLIMP-1 [38,39] need to be explored
in this context. Moreover, we do not provide data on intrahepatic
HCV-specific T cell responses. However, almost all IHLs show
very high 2B4 expression levels. Thus, we would expect that IHLs
should show similar response patterns as peripheral blood 2B4-
high HCV-specific CD8+ T cells.
In summary we suggest that 2B4 could be both a marker of
CD8+ T cell dysfunction and a potential target for immunointer-
ventions. These findings might be of importance for future
development of novel therapies for chronic HCV aiming to
achieve immune control.
Methods
Patient material
Heparinized peripheral whole blood was collected from acute
hepatitis B virus (HBV) and hepatitis C virus (HCV) infected
patients (n=6 and n=13, respectively) as well as from persistently
HCV infected patients (n=86). Healthy volunteers or samples
retrieved from the internal blood donation centre (n=49) were
used as controls. Liver tissue was derived from tumour patients
who underwent partial liver resection for evaluation of potential
liver metastases or from PSC patients.
Ethics approval
Written informed consent was obtained from all patients. Ethics
approval for this study was obtained by the local ethics committee
of Hannover Medical School. All patients were seen in the
outpatient clinic of the Department for Gastroenterology,
Hepatology and Endocrinology at Hannover Medical School,
Germany. Written informed consent was obtained from all
patients involved in this study.
Preparation of PBMCs and intrahepatic lymphocytes
Isolation of peripheral blood mononuclear cells (PBMC) was
performed using standard Ficoll Density Centrifugation method.
Intrahepatic lymphocytes (IHL) were isolated from liver tissue
samples by mechanical disruption through a 70 mm nylon mesh
and separated by density centrifugation after washing.
Monoclonal antibodies and MHC class I complexes
Mouse anti-human fluorochrome-conjugated monoclonal anti-
bodies were purchased as follows: anti-2B4 clone C1.7 (Beckman
Coulter, Fullerton, CA, USA), anti-CCR7 (R&D Systems, Minne-
apolis, MN, USA), anti-PD1 (BioLegend Inc., San Diego, CA,
USA), rat anti-SAP and secondary anti-rat IgG (Cell Signaling
Technology, Danvers, MA, USA). All other antibodies and mouse
IgG isotype controls were obtained from BD Pharmingen (Becton
Dickinson, Heidelberg, Germany). For in vitro blocking and cross-
linking experiments the following monoclonal antibodies were used
at a concentration of 5 mg/ml each: purified anti-2B4 (clone C1.7,
Beckman Coulter, Fullerton, CA, USA), functional grade purified
anti-2B4 (clone eBioPP35), functional grade purified anti-PDL-1
(clone MIH1) and functional grade purified mouse IgG1 isotype
control (eBioscience, San Diego, CA, USA). PE-labelled HLA-
A*0201 restricted iTag MHC Class I Tetrameric Complexes
(tetramers) specific for CMV-pp65 495–504 (NLVPMVATV),
EBV-BMLF1 259–267 (GLCTLVAML), influenza A Matrix
(influenza-A (IV)) Protein 58–66 (GILGFVFTL), HCV-NS3
1073-1082 (NS3–1073) derived peptide (CINGVCWTV)- HCV-
NS3 1406–1415 (KLVALGINAV), HCV-core 35–44
(YLLPRRGPRL), HCV-core 132–140 (ADLMGYIPLV), HCV-
NS4B 1789–1796 (SLMAFTAAV), HCV-NS5A 2252–2260
(ILDSFDPLV), HCV-NS5B 2594–2602 (ALYDVVTKL) and
HCV-E2 614v621 (RLWHYPCTV) were purchased from Beck-
man Coulter Inc. (Fullerton, CA, USA). Tetramer staining was
considered positive if a distinct population of positive cells could be
discriminated. Moreover, at least 0.02% of CD8+ T cells were
required to be considered as positive.
Synthetic MHC class I peptides
Antigenic HLA-A*0201 restricted peptides were purchased
from ProImmune Ltd. (Oxford, UK). Peptides were dissolved in
2B4 on HCV-Specific CD8+ T Cells
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as stock solution. Purity of all peptides was .98%. Final DMSO
concentration during T cell culture never exceeded 0.1%. Amino
acid sequences of the specific peptides are identical to those of the
respective MHC Class I Tetrameric Complexes used.
Analysis of PBMC by flow cytometry
Expression analysis of 2B4 on lymphocytes was performed
directly ex vivo after PBMC isolation and detection of antigen-
specific CD8+ T cells was performed as described elsewhere [40].
Appropriate unstained and FMO (fluorescence minus one)
controls were performed for adjustment of gating. Samples were
analysed on a flow cytometer (FACSCalibur or FACSCantoII,
Becton Dickinson, Heidelberg, Germany) within 30 minutes.
Analysis of FACS data was performed using FlowJo Software
(TreeStar Inc., San Diego, CA, USA).
In vitro culture of T cells
Frozen PBMCs were resuspended in RPMI-1640 (Invitrogen,
Karlsruhe, Germany) supplied with 10% human AB-Serum
(Cambrex, East Rutherford, NJ, USA), non-essential amino acids
and sodium private (Invitrogen, Karlsruhe, Germany), 2 mM
HEPES (Invitrogen, Karlsruhe, Germany) and Penicillin/Strep-
tomycin (100U/ml Penicillin and 100 mg/ml Streptomycin; PAA,
Pasching, Austria). 3610
5 PBMCs per well and condition were
stimulated in 96-well U-bottom plates (Sarstedt GmbH, Nu ¨m-
brecht, Germany) at 37uC and 5% CO2. Experiments were set up
in multiple replicates if possible. Medium alone or peptide alone
with IgG1 isotype control antibodies served as a negative control.
Respective antigenic peptides were added at optimal concentra-
tions as mentioned above.
Enumeration of antigen-specific CD8+ T cells after in vitro
culture
The frequency of antigen-specific CD8+ T cells tetramer
staining was analyzed after in vitro expansion of cells after seven
days in healthy individuals and after ten days for chronic HCV
patients. Human recombinant IL-2 (Invitrogen, Karlsruhe,
Germany) was added at day 3 or 5 in concentrations of 5U/ml,
respectively. For healthy individuals changes in proliferation of
virus-specific CD8+ T cells was analyzed by calculating the
stimulation index (SI) of samples with peptide+2B4 cross-linking in
relation to peptide stimulation alone. Grouping of cell samples into
2B4-low and 2B4-high was done according to the ex vivo
expression levels (MFI) of 2B4 on the respective tetramer-positive
CD8+ T cell. Cut-offs were set according to the average 2B4 MFI
calculated for all tetramer-positive CD8+ T cells analyzed,
respectively.
CFSE proliferation assay
Proliferation of bulk and antigen-specific CD8+ T cells was
analyzed by CFSE staining exactly as described previously [40].
Cells were stained with 4 mM CFSE prior to culture. After 7 days
of in vitro culture the percentage of dividing CFSE-low cells was
analyzed by flow cytometry.
Analysis of CD8+ T cell effector functions
Degranulation (CD107a/b expression) as a surrogate marker
for cytotoxicity was analyzed after in vitro stimulation of PBMC by
flow cytometry as previously described [40]. In addition, 2B4+/
CD8+ and 2B4-/CD8+ T cells were sorted by flow cytometry (BD
FACSAria, Becton Dickinson, Heidelberg, Germany), incubated
with anti-CD3/28 beads and stained for CD107a/b. IFNc
production of CD8+ T cells was investigated by intracellular
cytokine staining after 6h in vitro stimulation with peptides or anti-
CD3/28 beads and analyzed by flow cytometry [40].
Annexin-V staining
Determination of the viability of CD8+ T cells was performed
after 3 days in vitro culture by staining for Annexin-V using the
Annexin-V Staining Kit (Becton Dickinson, Heidelberg, Germany)
according to manufacturer’s protocol. PBMC from healthy
individuals were stimulated by anti-CD3/28 and additional 2B4
cross-linking.
Intracellular staining for SAP
Intracellular staining of the 2B4 signalling adaptor molecule
SLAM-associated protein (SAP) was performed in peripheral or
intrahepatic lymphocytes using the BD CytoPerm/Wash Buffer
Kit (BD Pharmingen). After surface staining cells were fixed and
following permeabilization stained using anti-SAP antibody,
detection was performed using a secondary antibody. Cells were
then analyzed on a flow cytometer.
Statistical analyses
For descriptive means statistics are expressed as mean values 6
standard deviations. Statistical analysis of stimulation experiments
were performed using considered two-tailed unpaired Student’s T
tests. Increase of effector functions were considered significant if
the calculated SI referring to the medium or peptide only sample
were #2.0. Man-Whitney U-Tests were used for analyzing
differences in 2B4 expressions. For calculating differences in
responsiveness of chronic hepatitis C patients to peptide
stimulation or additional 2B4 cross-linking or PD1 blockade a
simple Chi-Square Test was used. P values of ,0.05 were
considered as significant.
Accession numbers
Accession Numbers and IDs of human proteins referred to in
this manuscript were received from UniProt (http://www.ebi.ac.
uk/uniprot/)
– 2B4 (alternative names: CD244) Accession Number Q9BZW8
– CD48 (alternative names: B-lymphocyte activation marker
BLAST-1) Accession Number P09326
– SAP (SLAM-associated protein, alternative name: SH2
domain-containing protein 1A, SH2D1A) Accession Number:
O60880
– EAT-2 (EWS/FLI1-activated transcript 2, alternative name:
SH2 domain-containing protein 1B, SH2D1B) Accession
Number: O14796
– PD1 (Programmed cell death protein 1, alternative names:
CD279, PDCD1) Accession Number: Q15116
– PDL-1 (Programmed cell death 1 ligand 1, alternative names:
CD274, PDCD1L1) Accession Number: Q9NZQ7
Supporting Information
Figure S1 Degranulation of sorted 2B4+/CD8+ and 2B4-/
CD8+ T cells. PBMCs were sorted into 2B4+ (white bars) and
2B4- CD8+ (grey bars) T cells and stimulated in vitro for analyzing
their degranulation. Only 2B4+ CD8+ T cells showed an
increased expression of CD107a/b. Stimulation indices (SI)
referring to medium control are given; n=7.
(TIF)
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were stained for Annexin-V content after 3 days stimulation of
PBMCs with or without anti-CD3/28 and with or without 2B4
cross-linking in vitro. No difference in Annexin-V expression upon
additional 2B4 cross-linking could be seen. Percentages of
Annexin-V positive CD8+ T cells are given; n=5.
(TIF)
Figure S3 Effects of 2B4 cross-linking versus 2B4 blockade on
the expansion of HCV-specific CD8+ T cells. Expansion of HCV-
specific CD8+ T cells from chronic hepatitis C patients upon
peptide stimulation and additional 2B4 cross-linking or 2B4
blocking was analyzed by tetramer-staining after 10 days.
Responsiveness towards 2B4 cross-linking or 2B4 blockade varied
with 2B4 expression levels on tetramer-positive cells ex vivo. FACS
plots of three representative cell lines are shown, frequencies of
tetramer-positive cells are indicated. Cells were gated on CD14/
CD19/CD56-negative and CD8+ T cells.
(TIF)
Table S1 2B4 expression levels and autologous viral sequences.
Expression levels of 2B4 on CD8+ T cells specific for the HCV
NS3-1073 and NS3-1406 epitopes were analyzed, frequency and
mean fluorescence intensities (MFI) of 2B4 are indicated.
Autologous viral sequences of these two epitopes were analyzed
by sequencing in order to identify viral escape mutations.
Deviations from the wild type sequences used for peptides and
tetramers are indicated in bold and underlined, the respective
HCV genotype (HCV GT) is given.
(TIF)
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